Mark Evans

Mark Evans, PhD
Senior Scientist

Mark Evans is a Senior Scientist at Talisman Therapeutics. He is responsible for conducting experimental work and managing ongoing project activities.

Prior to joining Talisman, Mark worked as a Postdoctoral Fellow at the Gladstone Institutes in San Francisco, where he investigated the contribution of DNA damage to Alzheimer’s disease.

Mark has a PhD in Neuroscience from King’s College London, where he studied the cellular mechanisms underlying plasticity at the axon initial segment. He obtained his degree in Biochemistry from the University of Bath.